Inspire Corporate Bond ETF (AMEX: IBD) Stock Competitors & Peer Comparison

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBMPX has a market cap of 394.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBMPX trades at $9.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBMPX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBMPX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VBMPX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBMPX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBTIX has a market cap of 394.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBTIX trades at $9.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBTIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBTIX's ROE of +0.35%. Regarding short-term risk, IBD is more volatile compared to VBTIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBTIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBTLX has a market cap of 393.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBTLX trades at $9.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBTLX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBTLX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VBTLX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBTLX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BND has a market cap of 392.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BND trades at $71.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BND's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BND's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to BND. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BND's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTBNX has a market cap of 383.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTBNX trades at $9.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTBNX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTBNX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VTBNX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTBNX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTABX has a market cap of 121.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTABX trades at $18.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTABX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTABX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VTABX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTABX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTIFX has a market cap of 121.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTIFX trades at $28.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTIFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTIFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VTIFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTIFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BFAFX has a market cap of 99.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BFAFX trades at $10.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BFAFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BFAFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BFAFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BFAFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SGOV has a market cap of 96B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SGOV trades at $100.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SGOV's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to SGOV's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SGOV. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SGOV's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTIP has a market cap of 70.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTIP trades at $49.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTIP's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTIP's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VTIP. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTIP's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBIRX has a market cap of 69.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBIRX trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBIRX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBIRX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VBIRX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBIRX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BSV has a market cap of 69B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BSV trades at $76.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BSV's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BSV's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to BSV. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BSV's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FXNAX has a market cap of 68.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FXNAX trades at $10.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FXNAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FXNAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FXNAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FXNAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VICSX has a market cap of 68.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VICSX trades at $21.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VICSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VICSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VICSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VICSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BAGSX has a market cap of 57.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BAGSX trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BAGSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BAGSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BAGSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BAGSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BAGIX has a market cap of 57.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BAGIX trades at $9.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BAGIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BAGIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BAGIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BAGIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, WOBDX has a market cap of 52.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while WOBDX trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas WOBDX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to WOBDX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to WOBDX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check WOBDX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JCBZX has a market cap of 52.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JCBZX trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JCBZX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JCBZX's ROE of +0.09%. Regarding short-term risk, IBD is more volatile compared to JCBZX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JCBZX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBILX has a market cap of 51.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBILX trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBILX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBILX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VBILX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBILX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VSCSX has a market cap of 51.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VSCSX trades at $21.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VSCSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VSCSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VSCSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VSCSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VCSH has a market cap of 51.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VCSH trades at $77.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VCSH's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VCSH's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VCSH. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VCSH's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VGIT has a market cap of 49.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VGIT trades at $57.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VGIT's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VGIT's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VGIT. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VGIT's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTEAX has a market cap of 47.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTEAX trades at $19.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTEAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTEAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VTEAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTEAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VTEB has a market cap of 47.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VTEB trades at $48.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VTEB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VTEB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VTEB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VTEB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BIL has a market cap of 47B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BIL trades at $91.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BIL's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BIL's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to BIL. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BIL's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IEF has a market cap of 46.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IEF trades at $90.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IEF's P/E ratio is -1227.19. In terms of profitability, IBD's ROE is +0.00%, compared to IEF's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to IEF. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IEF's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BCOIX has a market cap of 45.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BCOIX trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BCOIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BCOIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BCOIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BCOIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BCOSX has a market cap of 45.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BCOSX trades at $10.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BCOSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BCOSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BCOSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BCOSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, MUB has a market cap of 44.8B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while MUB trades at $102.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas MUB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to MUB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to MUB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check MUB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FTBFX has a market cap of 42.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FTBFX trades at $9.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FTBFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FTBFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FTBFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FTBFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IUSB has a market cap of 42.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IUSB trades at $44.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IUSB's P/E ratio is 10.64. In terms of profitability, IBD's ROE is +0.00%, compared to IUSB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to IUSB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IUSB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, TLT has a market cap of 41.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while TLT trades at $81.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas TLT's P/E ratio is -6.46. In terms of profitability, IBD's ROE is +0.00%, compared to TLT's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to TLT. This indicates higher risk in terms of short-term price fluctuations for IBD.Check TLT's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JPST has a market cap of 40.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JPST trades at $50.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JPST's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JPST's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to JPST. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JPST's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, MBB has a market cap of 39B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while MBB trades at $91.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas MBB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to MBB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to MBB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check MBB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, LQD has a market cap of 32.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while LQD trades at $104.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas LQD's P/E ratio is 31.65. In terms of profitability, IBD's ROE is +0.00%, compared to LQD's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to LQD. This indicates higher risk in terms of short-term price fluctuations for IBD.Check LQD's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, GIBRX has a market cap of 31.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while GIBRX trades at $23.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas GIBRX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to GIBRX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to GIBRX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check GIBRX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, GIBIX has a market cap of 31.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while GIBIX trades at $23.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas GIBIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to GIBIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to GIBIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check GIBIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, GIBAX has a market cap of 31.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while GIBAX trades at $22.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas GIBAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to GIBAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to GIBAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check GIBAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, GIBCX has a market cap of 31.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while GIBCX trades at $22.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas GIBCX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to GIBCX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to GIBCX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check GIBCX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, GIBLX has a market cap of 31.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while GIBLX trades at $22.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas GIBLX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to GIBLX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to GIBLX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check GIBLX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, DBLTX has a market cap of 30.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while DBLTX trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas DBLTX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to DBLTX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to DBLTX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check DBLTX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, DLTNX has a market cap of 30.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while DLTNX trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas DLTNX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to DLTNX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to DLTNX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check DLTNX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JAAA has a market cap of 28.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JAAA trades at $50.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JAAA's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JAAA's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to JAAA. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JAAA's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IBFFX has a market cap of 28.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IBFFX trades at $12.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IBFFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to IBFFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to IBFFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IBFFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, MWTIX has a market cap of 28.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while MWTIX trades at $8.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas MWTIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to MWTIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to MWTIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check MWTIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PDBZX has a market cap of 27B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PDBZX trades at $11.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PDBZX's P/E ratio is 34.65. In terms of profitability, IBD's ROE is +0.00%, compared to PDBZX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to PDBZX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PDBZX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FBND has a market cap of 26.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FBND trades at $44.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FBND's P/E ratio is 8.76. In terms of profitability, IBD's ROE is +0.00%, compared to FBND's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to FBND. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FBND's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JBFRX has a market cap of 26.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JBFRX trades at $13.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JBFRX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JBFRX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to JBFRX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JBFRX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JHBIX has a market cap of 26.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JHBIX trades at $13.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JHBIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JHBIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to JHBIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JHBIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, JHNBX has a market cap of 26.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while JHNBX trades at $13.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas JHNBX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to JHNBX's ROE of -0.07%. Regarding short-term risk, IBD is more volatile compared to JHNBX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check JHNBX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SHY has a market cap of 24.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SHY trades at $81.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SHY's P/E ratio is 3692.73. In terms of profitability, IBD's ROE is +0.00%, compared to SHY's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SHY. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SHY's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, AFTFX has a market cap of 24.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while AFTFX trades at $12.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas AFTFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to AFTFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to AFTFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check AFTFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, XLC has a market cap of 22.8B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while XLC trades at $110.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas XLC's P/E ratio is 15.10. In terms of profitability, IBD's ROE is +0.00%, compared to XLC's ROE of +0.00%. Regarding short-term risk, IBD is less volatile compared to XLC. This indicates lower risk in terms of short-term price fluctuations for IBD.Check XLC's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, NHMCX has a market cap of 22.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while NHMCX trades at $18.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas NHMCX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to NHMCX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to NHMCX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check NHMCX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VCORX has a market cap of 22.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VCORX trades at $8.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VCORX's P/E ratio is 15.29. In terms of profitability, IBD's ROE is +0.00%, compared to VCORX's ROE of +0.09%. Regarding short-term risk, IBD is more volatile compared to VCORX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VCORX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VCOBX has a market cap of 22.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VCOBX trades at $17.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VCOBX's P/E ratio is 15.28. In terms of profitability, IBD's ROE is +0.00%, compared to VCOBX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VCOBX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VCOBX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IGSB has a market cap of 22.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IGSB trades at $51.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IGSB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to IGSB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to IGSB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IGSB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, ANBEX has a market cap of 20.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while ANBEX trades at $8.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas ANBEX's P/E ratio is -2.14. In terms of profitability, IBD's ROE is +0.00%, compared to ANBEX's ROE of -0.40%. Regarding short-term risk, IBD is more volatile compared to ANBEX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check ANBEX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PFBPX has a market cap of 20.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PFBPX trades at $9.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PFBPX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PFBPX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to PFBPX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PFBPX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PFORX has a market cap of 20.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PFORX trades at $9.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PFORX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PFORX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to PFORX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PFORX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PFOAX has a market cap of 20.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PFOAX trades at $9.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PFOAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PFOAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to PFOAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PFOAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IGIB has a market cap of 18.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IGIB trades at $51.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IGIB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to IGIB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to IGIB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IGIB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IEI has a market cap of 18B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IEI trades at $114.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IEI's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to IEI's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to IEI. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IEI's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, USFR has a market cap of 17.8B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while USFR trades at $50.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas USFR's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to USFR's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to USFR. This indicates higher risk in terms of short-term price fluctuations for IBD.Check USFR's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PULS has a market cap of 17.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PULS trades at $49.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PULS's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PULS's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to PULS. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PULS's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, USIG has a market cap of 17.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while USIG trades at $49.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas USIG's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to USIG's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to USIG. This indicates higher risk in terms of short-term price fluctuations for IBD.Check USIG's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VMBS has a market cap of 17B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VMBS trades at $45.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VMBS's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VMBS's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VMBS. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VMBS's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, HYG has a market cap of 17B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while HYG trades at $78.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas HYG's P/E ratio is 10.80. In terms of profitability, IBD's ROE is +0.00%, compared to HYG's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to HYG. This indicates higher risk in terms of short-term price fluctuations for IBD.Check HYG's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, LUBAX has a market cap of 16.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while LUBAX trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas LUBAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to LUBAX's ROE of +0.09%. Regarding short-term risk, IBD is more volatile compared to LUBAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check LUBAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VUBFX has a market cap of 15.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VUBFX trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VUBFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VUBFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VUBFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VUBFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FTRBX has a market cap of 15.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FTRBX trades at $9.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FTRBX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FTRBX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FTRBX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FTRBX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VGLT has a market cap of 15B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VGLT trades at $52.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VGLT's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VGLT's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to VGLT. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VGLT's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PYLD has a market cap of 14.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PYLD trades at $25.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PYLD's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PYLD's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to PYLD. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PYLD's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FIQZX has a market cap of 13.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FIQZX trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FIQZX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FIQZX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FIQZX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FIQZX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BIMSX has a market cap of 13.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BIMSX trades at $10.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BIMSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BIMSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BIMSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BIMSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SCHR has a market cap of 13B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SCHR trades at $23.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SCHR's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to SCHR's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SCHR. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SCHR's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PFF has a market cap of 13B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PFF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PFF's P/E ratio is 3.72. In terms of profitability, IBD's ROE is +0.00%, compared to PFF's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to PFF. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PFF's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BFIFX has a market cap of 12.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BFIFX trades at $9.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BFIFX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BFIFX's ROE of -0.00%. Regarding short-term risk, IBD is more volatile compared to BFIFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BFIFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, VBLTX has a market cap of 12.8B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while VBLTX trades at $15.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas VBLTX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to VBLTX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to VBLTX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check VBLTX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BSBIX has a market cap of 12.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BSBIX trades at $9.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BSBIX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BSBIX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BSBIX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BSBIX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BSBSX has a market cap of 12.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BSBSX trades at $9.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BSBSX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BSBSX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to BSBSX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BSBSX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, NHMRX has a market cap of 12.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while NHMRX trades at $13.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas NHMRX's P/E ratio is 53.86. In terms of profitability, IBD's ROE is +0.00%, compared to NHMRX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to NHMRX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check NHMRX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, NHMFX has a market cap of 12.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while NHMFX trades at $13.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas NHMFX's P/E ratio is 53.86. In terms of profitability, IBD's ROE is +0.00%, compared to NHMFX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to NHMFX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check NHMFX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, NHMAX has a market cap of 12.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while NHMAX trades at $13.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas NHMAX's P/E ratio is 53.90. In terms of profitability, IBD's ROE is +0.00%, compared to NHMAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to NHMAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check NHMAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, NHCCX has a market cap of 12.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while NHCCX trades at $13.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas NHCCX's P/E ratio is 53.86. In terms of profitability, IBD's ROE is +0.00%, compared to NHCCX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to NHCCX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check NHCCX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FBNDX has a market cap of 11.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FBNDX trades at $7.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FBNDX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FBNDX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FBNDX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FBNDX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FIKQX has a market cap of 11.6B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FIKQX trades at $7.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FIKQX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FIKQX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FIKQX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FIKQX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, FIPDX has a market cap of 11.5B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while FIPDX trades at $8.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas FIPDX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to FIPDX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to FIPDX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check FIPDX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SPIB has a market cap of 11.4B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SPIB trades at $32.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SPIB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to SPIB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SPIB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SPIB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SUB has a market cap of 11.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SUB trades at $105.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SUB's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to SUB's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SUB. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SUB's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PAAA has a market cap of 11.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PAAA trades at $51.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PAAA's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PAAA's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to PAAA. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PAAA's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, BKMS has a market cap of 11.2B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while BKMS trades at $25.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas BKMS's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to BKMS's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to BKMS. This indicates higher risk in terms of short-term price fluctuations for IBD.Check BKMS's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IIBAX has a market cap of 11.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IIBAX trades at $8.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IIBAX's P/E ratio is 6.22. In terms of profitability, IBD's ROE is +0.00%, compared to IIBAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to IIBAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IIBAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, IIBZX has a market cap of 11.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while IIBZX trades at $8.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas IIBZX's P/E ratio is 6.22. In terms of profitability, IBD's ROE is +0.00%, compared to IIBZX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to IIBZX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check IIBZX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, TLH has a market cap of 11.1B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while TLH trades at $95.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas TLH's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to TLH's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to TLH. This indicates higher risk in terms of short-term price fluctuations for IBD.Check TLH's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, STYAX has a market cap of 10.9B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while STYAX trades at $10.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas STYAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to STYAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to STYAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check STYAX's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, DFCF has a market cap of 10.7B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while DFCF trades at $40.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas DFCF's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to DFCF's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to DFCF. This indicates higher risk in terms of short-term price fluctuations for IBD.Check DFCF's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, SPTL has a market cap of 10.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while SPTL trades at $24.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas SPTL's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to SPTL's ROE of +0.00%. Regarding short-term risk, IBD is more volatile compared to SPTL. This indicates higher risk in terms of short-term price fluctuations for IBD.Check SPTL's competition here

Inspire Corporate Bond ETF (AMEX: IBD) plays a significant role within the Financial Services sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBD stands at 468.5M. In comparison, PTIAX has a market cap of 10.3B. Regarding current trading prices, IBD is priced at $23.32 on the AMEX, while PTIAX trades at $19.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBD currently has a P/E ratio of N/A, whereas PTIAX's P/E ratio is N/A. In terms of profitability, IBD's ROE is +0.00%, compared to PTIAX's ROE of N/A. Regarding short-term risk, IBD is more volatile compared to PTIAX. This indicates higher risk in terms of short-term price fluctuations for IBD.Check PTIAX's competition here